Thursday, August 01, 2024

Don't be an Alpha-Gal

ProMED tells the sad tale of a repatriated Arkansasan who started a BBQ restaurant and then came down with the tick-bourne meat allergy you may have heard of in a keto horror story somewhere:
Alpha-gal (galactose-alpha-1,3-galactose) is a sugar molecule found in most mammals, but not in humans. Kennedy said because the molecule is foreign to our bodies, when it gets introduced, say, through the saliva of a tick, it can result in serious allergic reactions to red meat and other mammal byproducts like milk or gelatin.

"So when a tick bites you, it injects saliva. Therefore, it's possible that's the route of first sensitization that's required for allergy," Kennedy said. "It is a vector-borne type of allergy that we didn't even know existed until 2007."

But how exactly does the illness manifest from the tick to human? Researchers aren't really sure.

"I wish we knew who would be at most risk, and that's another thing that needs to happen as far as the research goes," [Kennedy] said. "I've lived in Arkansas my whole life, and I can tell you I've had millions of tick bites, right? And I don't have alpha-gal. So why do my patients have it, when they get a tick bite? Is it the tick? Is it the person? What happens there?"
There is apparently some hope of recovery if you leave the range of the lone star tick and see an allergist.

Wednesday, April 03, 2024

BioNIHTech

It's been so long I've stopped counting. I was planning to comment on #iamahorse, the FDA's tweet-deleting settlement of a lawsuit against them for practicing medicine without a license interfering with the distribution of ivermectin. But then this came up...

The bad cat reports on another lawsuit, in which the NIH is suing BioNIHTech BioNTech for royalties on their COVID vaccine.
the mRNA payload came from NIH to moderna and moderna paid them lavish royalties in the hundreds of millions, possibly billions whose recipients at NIH were never really disclosed (and astonishingly are not required to be). these often go to individuals, not the NIH as a whole. fauci and collins may well be very rich men from this. (and their alleged “nothing to see here disclosures” all oddly seem to predate the commencement of the licensing lucre.)

many searched high and low but bioNtech remained a mystery.

where did they get their mRNA payload for their incredibly profitable product and how did they do it as quickly as moderna who had clearly gotten the cheat codes from the selfsame “scientists” who funded the virus’s creation?

well, now we know: they got it from the same place that moderna did: the NIH.

then they seemingly skipped out on the check. and now they are getting hit with a notice of default.

doopsie.
If it were me, I might gamble that the NIH was raking enough in from Moderna and try to skip out on the check. But it seems they lost the bet that the NIH would pass up Pfizer-level funds to keep this quiet. How much of a secret can it have been that a largely unqualified company also came up with a never-yet-successful mRNA approach to vaccinate against the same disease?